SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000893220-05-002607
Filing Date
2005-11-09
Accepted
2005-11-09 17:24:56
Documents
6
Period of Report
2005-09-30

Document Format Files

Seq Description Document Type Size
1 IDERA PHARMACEUTICALS, INC. FORM 10-Q b57608ipe10vq.htm 10-Q 253984
2 EX-10.1 EMPLOYMENT AGREEMENT - AGRAWAL b57608ipexv10w1.txt EX-10.1 49135
3 EX-31.1 SECTION 302 CERTIFICATION OF C.E.O. b57608ipexv31w1.htm EX-31.1 6505
4 EX-31.2 SECTION 302 CERTIFICATION OF C.F.O. b57608ipexv31w2.htm EX-31.2 6514
5 EX-32.1 SECTION 906 CERTIFICATION OF C.E.O. b57608ipexv32w1.htm EX-32.1 3697
6 EX-32.2 SECTION 906 CERTIFICATION OF C.F.O. b57608ipexv32w2.htm EX-32.2 3710
  Complete submission text file 0000893220-05-002607.txt   325038
Mailing Address 345 VASSAR STREET CAMBRIDGE MA 02139
Business Address 345 VASSAR STREET CAMBRIDGE MA 02139 6176795500
IDERA PHARMACEUTICALS, INC. (Filer) CIK: 0000861838 (see all company filings)

IRS No.: 043072298 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-31918 | Film No.: 051191157
SIC: 2836 Biological Products, (No Diagnostic Substances)